Want to see KR:033270 full AI Analyst Report?
KOREA UNITED PHARM, INC. (033270) Revenue
KOREA UNITED PHARM, INC. Revenue
KOREA UNITED PHARM, INC. had a revenue of 77.22B in the quarter ending Jun 30, 2026, with 4.61%. This bring the company's revenue in the last twelve months to 298.08B, Increased 2.35%. In the fiscal year ending Dec 31, 2025, KOREA UNITED PHARM, INC. had annual revenue of 288.76B with 0.02% growth.
- Revenue (ttm)
- 298.08B
- Revenue Growth
- 0.85%
- P/S Ratio
- 0.85
- Revenue/Employee
- KRW 308,509,474
- Employees
- 936
- Market Cap
- KRW 245.35B
Revenue Chart
KOREA UNITED PHARM, INC. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 288.76B | 58.14M | 0.02% |
| Dec 31, 2024 | 288.71B | 9.76B | 3.50% |
| Dec 31, 2023 | 278.94B | 16.42B | 6.26% |
| Dec 31, 2022 | 262.52B | 41.48B | 18.77% |
| Dec 31, 2021 | 221.04B | 5.09B | 2.36% |
| Dec 31, 2020 | 215.95B | -5.36B | -2.42% |
| Dec 31, 2019 | 221.31B | 9.38B | 4.42% |
| Dec 31, 2018 | 211.94B | 14.91B | 7.57% |
| Dec 31, 2017 | 197.02B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.